YES. THIS.

"While political leaders have locked their borders, scientists have been shattering theirs, creating a global collaboration unlike any in history. Never before, researchers say, have so many experts in so many countries focused simultaneously on a single topic and w/such urgency"

tweet / quote of the year candidate

no. 6 from Adjuvant Capital (we are thrilled to be supporting @weare54gene alongside Y Combinator Better Ventures Fifty Years + others) cc: [email protected] adjuvantcapital.com/news/54gene/

delighted to see Atomo Diagnostics moving forward with their vision of deploying rapid PoC tests for HIV, COVID-19, and other infectious diseases in LMICs and beyond

MJ

👏👏👏

no. 7 from Adjuvant Capital (joining forces w/ Domain Associates, NEA, and Northpond Ventures in advancing ChromaCode, Inc. next-gen molecular dx and expanding access / availability for SARS-CoV-2 testing) cc: ChuckPetty adjuvantcapital.com/news/perfectin…

thrilled to share that Adjuvant Capital portfolio company @Themis_Bio has been acquired by Merck to supercharge vaccine programs for high burden infectious diseases, including SARS-CoV-2, chikungunya, and Lassa, among others statnews.com/2020/05/26/mer…

huge congrats to the entire THEMIS team, especially Erich Tauber and Katrin Ramsauer!! and can't wait to see what the landmark collaboration among @Themis_Bio, Merck, Institut Pasteur, since 1887, CEPI, and Center for Vaccine Research brings to the world adjuvantcapital.com/news/the-platf…

"While behind the likes of AstraZeneca, Moderna, Pfizer/BioNTech and CureVac, Merck hopes its expertise and slightly different mechanism of action may prove a tortoise over the hare victory." 🐢🐇🐢🐇🐢🐇🐢 fiercebiotech.com/biotech/merck-…

as the US / EU allocate billions toward SARS-CoV-2 vaccine procurement, it will be companies like SerumInstituteIndia and other developing country vaccine manufacturers (aka DCVMs) that make sure LMICs don't get left behind nytimes.com/2020/08/01/wor…

*after two weeks, receives text that COVID-19 test results are in* *logs into CityMD patient portal*

as Peter Kolchinsky once said, "rabies is a devil," and we couldn't agree more. excited to join OrbiMed Oceanpine F-Prime @HillhouseCap @msacapital, and others, supporting YishengBio to scale-up rabies PEP and develop other essential vaccines adjuvantcapital.com/news/yisheng-a…

👀 linkedin.com/jobs/view/2469…

Our friends at Univercells (@BiologicsforAll) are really living their truth as they prepare to make affordable bio-manufacturing capacity available in Senegal via a collaboration with great partners such as Institut Pasteur de Dakar and IRESSEF. 💛💛💛

“he needs to get his family to the airport. he needs two more days” an epic humanitarian failure. devastating. theatlantic.com/ideas/archive/…

MEDVEDEV